Performance

DYN +1.42%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
DYN	+3.04%	-4.81%	+1.42%	+4.38%	-46.79%	0.29	0.00%

Summary

DYN at a glance

DYN returned +1.42% over the past year and +4.38% a year over five years. Its worst drop in that year was -46.79%, smaller than 27% of stocks on Redstone, and its Sharpe ratio of 0.29 beats 40% of stocks on Redstone. It pays no dividends.

Ranking

How DYN ranks

Current Drawdown

-30.47%

Rolling Volatility

64.67%

Actions

Metrics

Risk Indicators

Alpha1.81%

Beta1.67x

Sharpe0.29

Sortino0.41

Omega1.05

Calmar0.03

Martin0.84

Profile

About DYN

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $3.5B
Listed: Sep 2020
Employees: 258
Headquarters: Waltham, MA
Website: dyne-tx.com

Comparisons

DYN: Dyne Therapeutics, Inc.

DYN at a glance

How DYN ranks

Current Drawdown

Rolling Volatility

About DYN

Related comparisons